5news.U.S. news, all in one place

BREAKING

› Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell › Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials › Podcast: One country musician is calling for other artists to oppose assault rifles › Bidets save you money and reduce waste — we tested the best options out there › 50+ products to make your life easier and our planet cleaner › Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love › A head-to-toe guide of how men should dress this spring, and where they should shop › 42 of the most useful travel products you can buy on Amazon › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell › Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials › Podcast: One country musician is calling for other artists to oppose assault rifles › Bidets save you money and reduce waste — we tested the best options out there › 50+ products to make your life easier and our planet cleaner › Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love › A head-to-toe guide of how men should dress this spring, and where they should shop › 42 of the most useful travel products you can buy on Amazon › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension

Business

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

CNBC · August 26, 2026 at 11:51 AM

The drug is a once-daily pill designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers.

Read the full article on CNBC ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.

More from CNBC

The post-penny economy: How cash rounding and credit card surcharges are changing what you pay

CNBC · 6 min ago

Nvidia earnings live updates: Q2 results, memory prices and AI outlook

CNBC · 9 min ago

Mark Walter's TWG Global says there's 'no fraud' amid probe of insurers' disclosures

CNBC · 12 min ago

Why we need ‘Human Reserved’ jobs, says Bill Gates—and how we can combat the worst of the AI upheaval

CNBC · 21 min ago

More in Business

Am I too old for Roth conversions? I’m 84 and my wife is 77. We have $8 million saved.

MarketWatch · 5 min ago

I raised 5 kids and refused to spend thousands on youth sports. I don't regret it.

Business Insider · 6 min ago

The post-penny economy: How cash rounding and credit card surcharges are changing what you pay

CNBC · 6 min ago

Nvidia earnings live updates: Q2 results, memory prices and AI outlook

CNBC · 9 min ago

I got the chance to speak to Dolly Parton, and she was full of great life lessons. These are my favorites.

Business Insider · 9 min ago

The ugly math on interest expenses, yields and the $40 trillion U.S. national debt

MarketWatch · 10 min ago